vs
Mayville Engineering Company, Inc.（MEC）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是Mayville Engineering Company, Inc.的1.5倍（$207.3M vs $134.3M），Mayville Engineering Company, Inc.净利率更高（-3.2% vs -62.0%，领先58.8%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 10.7%），Mayville Engineering Company, Inc.自由现金流更多（$10.2M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -8.8%）
Mayville Engineering Company（MEC）是总部位于美国的领先金属零部件、装配组件及定制工程解决方案供应商，主要服务农业、建筑、商用运输、国防、动力运动等领域的原始设备制造商客户，提供从原型开发到大规模量产的全流程服务。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
MEC vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $134.3M | $207.3M |
| 净利润 | $-4.4M | $-128.6M |
| 毛利率 | 6.8% | — |
| 营业利润率 | -4.1% | -54.7% |
| 净利率 | -3.2% | -62.0% |
| 营收同比 | 10.7% | 25.9% |
| 净利润同比 | -127.3% | 3.5% |
| 每股收益（稀释后） | $-0.22 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $134.3M | $207.3M | ||
| Q3 25 | $144.3M | $159.9M | ||
| Q2 25 | $132.3M | $166.5M | ||
| Q1 25 | $135.6M | $139.3M | ||
| Q4 24 | $121.3M | $164.6M | ||
| Q3 24 | $135.4M | $139.5M | ||
| Q2 24 | $163.6M | $147.0M | ||
| Q1 24 | $161.3M | $108.8M |
| Q4 25 | $-4.4M | $-128.6M | ||
| Q3 25 | $-2.7M | $-180.4M | ||
| Q2 25 | $-1.1M | $-115.0M | ||
| Q1 25 | $20.0K | $-151.1M | ||
| Q4 24 | $16.0M | $-133.2M | ||
| Q3 24 | $3.0M | $-133.5M | ||
| Q2 24 | $3.8M | $-131.6M | ||
| Q1 24 | $3.2M | $-170.7M |
| Q4 25 | 6.8% | — | ||
| Q3 25 | 11.0% | — | ||
| Q2 25 | 10.3% | — | ||
| Q1 25 | 11.3% | — | ||
| Q4 24 | 8.9% | — | ||
| Q3 24 | 12.6% | — | ||
| Q2 24 | 13.6% | — | ||
| Q1 24 | 13.0% | — |
| Q4 25 | -4.1% | -54.7% | ||
| Q3 25 | 0.0% | -106.9% | ||
| Q2 25 | 0.1% | -64.8% | ||
| Q1 25 | 1.2% | -102.6% | ||
| Q4 24 | 19.0% | -74.3% | ||
| Q3 24 | 4.2% | -94.6% | ||
| Q2 24 | 5.0% | -79.1% | ||
| Q1 24 | 4.7% | -151.9% |
| Q4 25 | -3.2% | -62.0% | ||
| Q3 25 | -1.9% | -112.8% | ||
| Q2 25 | -0.8% | -69.0% | ||
| Q1 25 | 0.0% | -108.5% | ||
| Q4 24 | 13.2% | -80.9% | ||
| Q3 24 | 2.2% | -95.7% | ||
| Q2 24 | 2.3% | -89.5% | ||
| Q1 24 | 2.0% | -156.8% |
| Q4 25 | $-0.22 | $-1.28 | ||
| Q3 25 | $-0.13 | $-1.81 | ||
| Q2 25 | $-0.05 | $-1.17 | ||
| Q1 25 | $0.00 | $-1.57 | ||
| Q4 24 | $0.76 | $-1.34 | ||
| Q3 24 | $0.14 | $-1.40 | ||
| Q2 24 | $0.18 | $-1.52 | ||
| Q1 24 | $0.16 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.5M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $240.7M | $-80.0M |
| 总资产 | $563.6M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $1.5M | $421.0M | ||
| Q3 25 | $1.2M | $202.5M | ||
| Q2 25 | $206.0K | $176.3M | ||
| Q1 25 | $183.0K | $127.1M | ||
| Q4 24 | $206.0K | $174.0M | ||
| Q3 24 | $178.0K | $150.6M | ||
| Q2 24 | $314.0K | $480.7M | ||
| Q1 24 | $314.0K | $112.3M |
| Q4 25 | $240.7M | $-80.0M | ||
| Q3 25 | $244.8M | $9.2M | ||
| Q2 25 | $246.8M | $151.3M | ||
| Q1 25 | $250.0M | $144.2M | ||
| Q4 24 | $251.8M | $255.0M | ||
| Q3 24 | $238.4M | $346.8M | ||
| Q2 24 | $238.1M | $432.4M | ||
| Q1 24 | $234.0M | $140.3M |
| Q4 25 | $563.6M | $1.5B | ||
| Q3 25 | $585.6M | $1.2B | ||
| Q2 25 | $433.7M | $1.3B | ||
| Q1 25 | $447.7M | $1.3B | ||
| Q4 24 | $445.6M | $1.5B | ||
| Q3 24 | $466.0M | $1.5B | ||
| Q2 24 | $488.2M | $1.6B | ||
| Q1 24 | $499.9M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.4M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $10.2M | $-100.8M |
| 自由现金流率自由现金流/营收 | 7.6% | -48.6% |
| 资本支出强度资本支出/营收 | 2.4% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $26.9M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $13.4M | $-99.8M | ||
| Q3 25 | $1.9M | $-91.4M | ||
| Q2 25 | $15.0M | $-108.3M | ||
| Q1 25 | $8.3M | $-166.5M | ||
| Q4 24 | $38.0M | $-79.3M | ||
| Q3 24 | $17.9M | $-67.0M | ||
| Q2 24 | $23.3M | $-77.0M | ||
| Q1 24 | $10.6M | $-190.7M |
| Q4 25 | $10.2M | $-100.8M | ||
| Q3 25 | $-1.1M | $-92.7M | ||
| Q2 25 | $12.5M | $-110.7M | ||
| Q1 25 | $5.4M | $-167.8M | ||
| Q4 24 | $35.6M | $-79.5M | ||
| Q3 24 | $15.1M | $-68.6M | ||
| Q2 24 | $19.2M | $-79.0M | ||
| Q1 24 | $7.8M | $-193.9M |
| Q4 25 | 7.6% | -48.6% | ||
| Q3 25 | -0.8% | -58.0% | ||
| Q2 25 | 9.5% | -66.5% | ||
| Q1 25 | 4.0% | -120.5% | ||
| Q4 24 | 29.4% | -48.3% | ||
| Q3 24 | 11.1% | -49.2% | ||
| Q2 24 | 11.7% | -53.7% | ||
| Q1 24 | 4.9% | -178.2% |
| Q4 25 | 2.4% | 0.5% | ||
| Q3 25 | 2.1% | 0.8% | ||
| Q2 25 | 1.8% | 1.5% | ||
| Q1 25 | 2.2% | 1.0% | ||
| Q4 24 | 1.9% | 0.1% | ||
| Q3 24 | 2.1% | 1.2% | ||
| Q2 24 | 2.5% | 1.4% | ||
| Q1 24 | 1.7% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 416.65× | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 6.03× | — | ||
| Q2 24 | 6.15× | — | ||
| Q1 24 | 3.28× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MEC
| Fabrication | $72.2M | 54% |
| Construction And Access | $19.2M | 14% |
| Tubes | $16.2M | 12% |
| Other Market | $11.9M | 9% |
| Agriculture | $7.7M | 6% |
| Military | $6.7M | 5% |
| Outdoor Sports | $1.7M | 1% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
